Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C W Moore

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Biochemical Pharmacology|September 7, 2000
Biochemical and cellular effects of c-Src kinase-selective pyrido[2, 3-d]pyrimidine tyrosine kinase inhibitorsA J Kraker, B G Hartl, A M Amar, et al.
Cellular and Molecular Biology (Noisy-Le-Grand, France)|February 15, 2002
The novel BLM3 gene encodes a protein that protects against lethal effects of oxidative damageD E Febres, A Pramanik, M Caton, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1993
Bleomycin affects cell wall anchorage of mannoproteins in Saccharomyces cerevisiaeR Beaudouin, S T Lim, J A Steide, et al.
Journal of Medicinal Chemistry|February 14, 1997
Tyrosine kinase inhibitors. 6. Structure-activity relationships among N- and 3-substituted 2,2'-diselenobis(1H-indoles) for inhibition of protein tyrosine kinases and comparative in vitro and in vivo studies against selected sulfur congenersH D Showalter, A D Sercel, B M Leja, et al.
Journal of Medicinal Chemistry|June 1, 2001
Soluble 2-substituted aminopyrido[2,3-d]pyrimidin-7-yl ureas. Structure-activity relationships against selected tyrosine kinases and exploration of in vitro and in vivo anticancer activityM C Schroeder, J M Hamby, C J Connolly, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Biochemical Pharmacology|September 7, 2000
Biochemical and cellular effects of c-Src kinase-selective pyrido[2, 3-d]pyrimidine tyrosine kinase inhibitorsA J Kraker, B G Hartl, A M Amar, et al.
Cellular and Molecular Biology (Noisy-Le-Grand, France)|February 15, 2002
The novel BLM3 gene encodes a protein that protects against lethal effects of oxidative damageD E Febres, A Pramanik, M Caton, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1993
Bleomycin affects cell wall anchorage of mannoproteins in Saccharomyces cerevisiaeR Beaudouin, S T Lim, J A Steide, et al.
Journal of Medicinal Chemistry|February 14, 1997
Tyrosine kinase inhibitors. 6. Structure-activity relationships among N- and 3-substituted 2,2'-diselenobis(1H-indoles) for inhibition of protein tyrosine kinases and comparative in vitro and in vivo studies against selected sulfur congenersH D Showalter, A D Sercel, B M Leja, et al.
Journal of Medicinal Chemistry|June 1, 2001
Soluble 2-substituted aminopyrido[2,3-d]pyrimidin-7-yl ureas. Structure-activity relationships against selected tyrosine kinases and exploration of in vitro and in vivo anticancer activityM C Schroeder, J M Hamby, C J Connolly, et al.
Pageof 5